College Students

“"I know from personal experience...getting anxious kids help early can be crucial in heading off more serious problems later in life."”

A Childhood Darkened by Severe Anxiety Becomes Brighter

Childhood anxiety, even severe and chronic, doesn’t necessarily stand in the way of success and achievement. But caring parents will do anything to help relieve their children of misery. Scott Stossel, the editor of The Atlantic magazine, tells his story of struggling, coping, and living a very productive life.

Read
“My introduction to college was defined by a series of irrational questions.”

My Success Over OCD

Two years ago I wondered if the horrible feeling, the gnawing in my stomach would ever leave. Inside my freshman dorm room, I lived in my own mind, fixated on my thoughts and tormented by irrational messages and faulty fears.

Read

Updates for 2014 CDLP Cohort

Find out what the 2014 Career Development Leadership Program cohort has been doing in 2014.

˃ “The CDLP was invaluable to my professional advancement.”
˃ “The program provided a wonderful opportunity to hear from leaders in the field and network with other young professionals.”
˃ “I would like to note that CDLP was directly helpful in the process of applying for grants.”
˃ Participating in the ADAA Career Development Leadership Program provided great momentum for 2014.

October 9: National Depression Screening Day

10/1/2014

Take an anonymous online screening or locate a mental health screening site, including those for college students and military and their families. Screening for depression is as important as screening for physical diseases because early identification makes treatment more effective.

Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment

Do you have problems with mood or anxiety?

The University of Illinois at Chicago is conducting a research study on mood and anxiety. This study is testing how treatments affect brain function, physiology, behavior, and mental health. 

Organization: 
The University of Illinois at Chicago
Principal Investigator: 
K. Luan Phan, MD
Eligibility Criteria: 

You may be eligible if

  • you are 18 to 65 years old.
  • you experience anxiety, worry, and/or depressed mood.
Exclusion Criteria: 
  • Interested volunteers should have no metal parts in their body and no major medical or neurological illness.
  • Patients who are currently undergoing psychotherapy (talk therapy) or taking certain medications that affect the brain may not qualify for the study. 
  • Women should not be pregnant or trying to become pregnant.
Contact: 
312-413-4763 or 888-686-5591; emotion@psych.uic.edu
Location: 
Chicago
State: 
Illinois
Study End Date: 
Wed, 2017-05-31

Suicide

Robin WilliamsADAA mourns the loss of Robin Williams and too many others whose lives have ended due to suicide. His tragic death illustrates the great need for increased public awareness of the grave risk that suicide poses.

Cognitive-Behavioral Therapy vs. Supportive Psychotherapy for Adults With Body Dysmorphic Disorder (BDD)

The purpose of this study is to learn which of two forms of therapy is more likely to help people who have body dysmorphic disorder (BDD). We are comparing cognitive-behavioral therapy (CBT), which is a promising new treatment for BDD, and supportive psychotherapy (SPT), which appears to be the most widely used therapy in the community to treat BDD and related problems, such as low self-esteem or problems with family members or friends.

Study Treatments

Organization: 
Brown University, Rhode Island Hospital
Principal Investigator: 
Katharine Phillips, MD
Eligibility Criteria: 

Adults (age18 or older):

  • Have BDD.
  • Live within driving distance of Boston, Massachusetts.
  • Meet further qualifications for this study.
Contact: 
Phone: 877-4MGH-BDD or email BDD@Lifespan.org
Location: 
Massachusetts General Hospital
State: 
Massachusetts
Study End Date: 
Sat, 2016-04-30

Integrated PTSD and Smoking Treatment

Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD.

Organization: 
The University of Texas at Austin
Principal Investigator: 
Mark B. Powers, PhD
Eligibility Criteria: 
  • Male and female patients ages 18 to 65 capable of providing informed consent
  • Willing and able to provide informed consent, attend all study visits and comply with the protocol
  •  Daily smoker for at least 3 months
  • Currently smoke an average of at least 8 cigarettes per day
  • Report a motivation to quit smoking in the next month of at least 5 on a 10-point scale
  • Meet criteria for current diagnosis of PTSD via structured clinical interview
Exclusion Criteria: 
  • Current diagnosis of a psychotic, eating, developmental, or bipolar disorder
  • Significant suicide risk as determined by structured interview
  • Psychoactive substance abuse or dependence (excluding nicotine dependence) within the past 6 months
  • Limited mental competency and the inability to give informed, voluntary, written consent to participate
  • Current use of any pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt
  • Current psychotherapy directed specifically toward treatment of PTSD
  • Use of other tobacco products
  • Planning on moving (outside of the immediate area) in the next 6 months
  • Insufficient command of the English language (i.e., cannot carry on a conversation with an interviewer in English or read associated text)

 

Contact: 
Brooke Kauffman, 512-471-1117; treatment@utexas.edu
Location: 
The University of Texas at Austin
State: 
Texas
Study End Date: 
Sat, 2018-06-30

Enhancing Panic and Smoking Reduction with D-Cycloserine

The purpose of the current study is to evaluate the efficacy of d-cycloserine in augmenting treatment of smoking cessation for individuals with panic attacks. Individuals will receive 7 weeks of panic- and smoking-reduction treatment (PSRT) and one pill of d-cycloserine (DCS) or one pill placebo one hour prior to sessions 3, 4, and 5 (i.e., 3 single doses). Participants will also be given nicotine replacement therapy as part of PSRT (i.e., the patch).

Principal Investigator: 
Jasper Smits, PhD
Eligibility Criteria: 
  • Male and female patients ages 18 to 65 capable of providing informed consent
  • Willing and able to provide informed consent, attend all study visits and comply with the protocol
  • Daily smoker for at least one year
  • Currently smoke an average of at least 10 cigarettes per day
  • Report a motivation to quit smoking in the next month of at least 5 on a 10-point scale
  • Evidence of panic attack within the past year and endorsement of smoking as an emotion regulation strategy (i.e., score at least a 78 on the SAEQ).
Exclusion Criteria: 
  • Subjects who do not use smoking as an emotion-regulation strategy 
  • Current diagnosis of a psychotic, eating, developmental, or bipolar disorder
  • Significant suicide risk as determined by structured interview
  • Pregnant women, lactating women, and women of childbearing potential who are not using medically accepted forms of contraception (e.g., IUD, oral contraceptives, barrier devices, condoms and foam, or implanted progesterone rods stabilized for at least 3 months)  
  • Psychoactive substance abuse or dependence (excluding nicotine dependence) within the past 6 months
  • Current use of isoniazid or ethionamide compounds
  • A history of significant medical condition and/or be deemed as currently unhealthy in the context of a complete physical examination
  • Limited mental competency and the inability to give informed, voluntary, written consent to participate
  • Current use of any pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt
  • Concurrent psychotherapy initiated within three months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of anxiety or mood disorder other than general supportive therapy initiated at least 3 months prior to the study
  • Use of other tobacco products
  • Plans to move outside of the immediate area in the next 6 months
  • Insufficient command of the English language

 

Contact: 
Brooke Kauffman, 512-471-1117; treatment@utexas.edu
Location: 
The University of Texas at Austin
State: 
Texas
Study End Date: 
Thu, 2016-09-15

 

ADAA is a national nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, OCD, PTSD, depression, and related disorders and to improving the lives of all people who suffer from them.

 

Privacy Policy 
© ADAA, 2010-2014